Bradley Julie MB
Known title: DirectorCIK: 0001333488
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
First Watch (FWRG) Featured in Growth Stock Roundups. First Watch Restaurant Group was highlighted in recent market roundups as a growth stock to watch, alongside other consumer discretionary names moving in after-hours trading. The company is currently trading near the upper end of its 52-week range, with an average analyst target of $19.10. These mentions reflect ongoing interest in the brand's expansion potential within the restaurant sector.
Transaction History
| GDRX | ▲ Buy | Grant | 2,464 | $0 | 7/8/2024 | View on chart |
| GDRX | ▲ Buy | Grant | 28,398 | $0 | 6/6/2024 | View on chart |
| FWRG | ▲ Buy | Grant | 5,194 | $0 | 5/23/2024 | View on chart |
| GDRX | ▲ Buy | Grant | 39,177 | $0 | 6/14/2023 | View on chart |
| FWRG | ▲ Buy | Grant | 5,555 | $0 | 5/24/2023 | View on chart |
| GDRX | ▲ Buy | Grant | 27,440 | $0 | 6/14/2022 | View on chart |
| FWRG | ▲ Buy | Grant | 6,854 | $0 | 5/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People
GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.
GoodRx Expands Savings Offering With Companion Family Plan for Pets and People. GoodRx has launched a Companion Family Plan that extends its healthcare savings to pets as well as household members. The company is positioning the new offering as a way to bring prescription and care discounts to the entire family, including animals, broadening the appeal of its platform. Separately, a recent market analysis listed GoodRx among stocks viewed as having mixed momentum. The company is already trading near a well-tested support level, providing some technical context around the announcement.